New insight into the enhanced effect of pegylated interferon-α

Authors

  • Hiromi Abe Ph.D,

    1. Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
    2. Laboratory for Digestive Diseases, Center for Genomic Medicine, RIKEN, Hiroshima, Japan
    3. Liver Research Project Center, Hiroshima University, Hiroshima, Japan
    Search for more papers by this author
  • C. Nelson Hayes Ph.D,

    1. Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
    2. Laboratory for Digestive Diseases, Center for Genomic Medicine, RIKEN, Hiroshima, Japan
    3. Liver Research Project Center, Hiroshima University, Hiroshima, Japan
    Search for more papers by this author
  • Kazuaki Chayama MD, Ph.D

    1. Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
    2. Laboratory for Digestive Diseases, Center for Genomic Medicine, RIKEN, Hiroshima, Japan
    3. Liver Research Project Center, Hiroshima University, Hiroshima, Japan
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

No abstract is available for this article.

Ancillary